Portal de Periódicos da CAPES

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2014; Elsevier BV; Volume: 25; Linguagem: Inglês

10.1093/annonc/mdu199

1569-8041

Martin Reck, Sanjay Popat, Niels Reinmuth, Dirk De Ruysscher, Keith M. Kerr, Solange Peters,

Cancer Genomics and Diagnostics

Primary lung cancer is the most common malignancy after non-melanocytic skin cancer with deaths from lung cancer exceeding those from any other type of malignancy worldwide [1]. While it has been the most important cause of cancer mortality in men since the 1960s, it has equalled breast cancer as a cause of mortality in women since the 1990s. To date, prevention and smoking cessation are still the main methods to reduce the death toll [2]. Lung cancer is still increasing both in incidence and mortality worldwide.